During the past decade, Heart & Vascular Institute of Florida conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart & Vascular Institute of Florida" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Heart & Vascular Institute of Florida" are "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Flutter" (1 trials) and "Bradycardia" (1 trials). Many other conditions were trialed in "Heart & Vascular Institute of Florida" in a lesser frequency.

Most popular intervention types in "Heart & Vascular Institute of Florida" are "Device" (5 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (2 trials), "AVERT" (1 trials), "Acetylsalicylic acid" (1 trials), "CINCOR™ System and contrast conservation unit (CCS-1)" (1 trials) and "Cardiac Resynchronization Therapy - MPP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart & Vascular Institute of Florida" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Heart & Vascular Institute of Florida". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Heart & Vascular Institute of Florida, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Heart & Vascular Institute of Florida, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".